NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English Recently Added Within 3 Months Remove constraint Recently Added: Within 3 Months Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

103. Estimated impact analysis of site-neutral provisions in the Lower Costs, More Transparency Act (H.R. 5378)

104. Estimating the cost and effects of adding a dental benefit to Medicare Part B

106. The evolution of hospital designations and payment in the U.S: implications for rural hospitals

108. Experiences, behaviors, and attitudes about COVID-19 for people with disabilities over time

109. Expiration of the USDA Supplemental Nutrition Assistance Program (SNAP) emergency allotments: increased food insufficiency highlights inadequacy of SNAP benefits after thrifty food plan revisions

110. Exploring the effects of Medicaid during childhood on the economy and the budget

111. FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations

113. FDA’s approach to overseeing online tobacco retailers needs improvement

116. Federal budgetary effects of the activities of the Center for Medicare & Medicaid Innovation

117. Federal subsidies for health insurance: 2023 to 2033

118. Federal survey sample size analysis: disability, language, and sexual orientation and gender identity

119. The Food and Drug Administration needs to improve the premarket tobacco application review process for electronic nicotine delivery systems to protect public health

120. For Medicaid-enrolled children diagnosed with lead toxicity in five states, documentation reviewed for diagnoses and treatment services raises concerns

123. Four in ten adults with disabilities experienced unfair treatment in health care settings, at work, or when applying for public benefits in 2022

124. Four states reviewed received increased Medicaid COVID-19 funding even though they terminated some enrollees’ coverage for unallowable or potentially unallowable reasons

125. The future of remote patient monitoring

126. Georgia could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control

127. Health information technology adoption and utilization in long-term and post-acute care settings

128. Health insurance marketplaces: issuer participation trends in non-metropolitan places, 2014-22

131. Healthcare workforce

132. Healthy eating Rx: improving nutrition through health care

134. High rates of prior authorization denials by some plans and limited state oversight raise concerns about access to care in Medicaid managed care

135. Home health agencies failed to report over half of falls with major injury and hospitalization among their Medicare patients

141. How administrative professionals see the effects of narrow networks and complex benefits

144. How can changes to Social Security improve benefits for Black and Hispanic beneficiaries?

148. How to identify and support emerging risk Medi-Cal members with complex social and behavioral needs: a diabetes case study

149. How will employer health insurance affect wages and Social Security finances?

150. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry

152. The impact of losing childhood Supplemental Security Income benefits on long-term education and health outcomes

153. The impact of past incarceration on later-life DI and SSI receipt

154. Improving access to primary care for underserved populations: a review of findings from five case studies and recommendations

155. Improving behavioral health through data-driven collaboration: a Santa Cruz County case study

156. In five states, there was no evidence that many children in foster care had a screening for sex trafficking when they returned after going missing

157. Inaccuracies in Medicare’s race and ethnicity data hinder the ability to assess health disparities

158. Income of working-age veterans receiving disability compensation

161. Indian Health Service: Many federal facilities are in fair or poor condition and better data are needed on medical equipment : report to congressional requesters

163. Institutional review board (IRB) review of individual patient expanded access submissions for investigational drugs and biological products: guidance for IRBs and clinical investigators

164. An insurance profile of rural America: chartbook : key facts about insurance coverage and healthcare access in rural America

166. Invisible children, invisible families: a blueprint for supporting the child care needs of American Indian and Alaska native families

168. Key strategies that states used for managing Medicaid and marketplace enrollment during the COVID-19 PHE

172. Linking state Medicaid data and birth certificates for maternal health research

177. Louisiana should improve its oversight of nursing homes’ compliance with requirements that prohibit employment of individuals with disqualifying background checks

181. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

185. Medi-Cal explained: Medi-Cal financing and spending

188. Medicaid managed care, maternal mortality review committees, and maternal health: a 12-state scan

190. Medicaid program integrity: Opportunities exist for CMS to strengthen use of state auditor findings and collaboration : report to congressional requesters

191. Medicaid support for infant and early childhood mental health: lessons from five states

193. Medical debt in New York State: estimates for large cities and towns, state legislative districts, congressional districts, and other geographic areas

197. Medicare Part B drugs: trends in spending and utilization, 2008-2021

199. Medicare Part D enrollee out-of-pocket spending: recent trends and projected impacts of the Inflation Reduction Act

200. Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives